ClinicalTrials.gov
public full text
Public Domain
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
To determine if Alvimopan during open or robotic radical cystectomy with urinary diversion results in quicker return of bowel function (GI-2 recovery = time to upper \[first toleration of solid food\] and lower \[first bowel movement\] gastrointestinal recovery) compared to placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy#877934
- Best evidence summary on gastrointestinal function recovery after radical cystectomy for bladder cancer#4738
- Efficacy of Transversus Abdominis Plane Block#889451
- Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence#869369
- Lap-guided vs Us-guided TAP Block in Pediatric Laparoscopy#857327
Record · ID 1033433
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive